Daiichi Sankyo is seen as one of Silverback Therapeutics's biggest rivals. Daiichi Sankyo was founded in 2005 in Chuo-ku, Tōkyō Prefecture. Like Silverback Therapeutics, Daiichi Sankyo also operates in the Pharmaceuticals sector. Daiichi Sankyo generates $13.4B more revenue than Silverback Therapeutics.
Byondis is one of Silverback Therapeutics's top competitors. Byondis was founded in 2007, and its headquarters is in Nijmegen, Gelderland. Like Silverback Therapeutics, Byondis also operates in the Biotechnology space. Byondis has 326 more employees than Silverback Therapeutics.
AstraZeneca is one of Silverback Therapeutics's top rivals. AstraZeneca was founded in 1999, and is headquartered in Cambridge, England. Like Silverback Therapeutics, AstraZeneca also works within the Pharmaceuticals sector. AstraZeneca generates $57.2B more revenue vs. Silverback Therapeutics.